Who owns ADIAL PHARMACEUTICALS INC?
- Ticker: ADIL
- CUSIP Number: 00688a205
Tip: Access positions for across all investors
Analyze quarterly positions in Adial Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adial Pharmaceuticals stock
Who bought or sold ADIAL PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Manchester Capital Management | 48k | $64k | 0% | Mar 2024 |
|
| Hrt Financial | 36k | $47k | 100% | Mar 2024 |
|
| BlackRock | 7.6k | $10k | 0% | Mar 2024 |
|
| UBS Group | 5.7k | $7.6k | 58% | Mar 2024 |
|
| Tower Research Capital | 4.6k | $6.2k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 2.5k | $3.3k | 303% | Mar 2024 |
|
| Headlands Technologies | 64.00 | $84.998400 | 100% | Mar 2024 |
|
| Benjamin F. Edwards & Company | 40.00 | $0 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 19.00 | $0 | -50% | Mar 2024 |
|
| Morgan Stanley | 15.00 | $19.999500 | -29% | Mar 2024 |
|
| Wells Fargo & Company | 11.00 | $14.999600 | 38% | Mar 2024 |
|
| Qube Research & Technologies | 8.00 | $11.000000 | 0% | Mar 2024 |
|
Who sold out of Adial Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Dec 2023 | 2.5k | $4.7k |
| Focused Wealth Management | Dec 2023 | 549.00 | $1.0k |